No abstract available.
Nose* ; Rhinoplasty*

No abstract available.
Bone and Bones* ; Dental Implants*

No abstract available.

No abstract available.
Pneumonectomy*

PURPOSE: One of the options to increase number of donor kidneys is to expand acceptable criteria of cadaver donors and to use marginal donor. But these donor acceptability hanve changed with time. In this study, We analyzed the results of renal allo-transplant donated from cadaver with high serum creatinine over 3.0 mg/dL. METHODS: we analyzed 3 cadaver donors with high serum creatinine (>3.0 mg/dL) among the cadaveric renal transplants operated at Soonchunhyang University Hospital from Jan. 1994 to Dec. 1999, retrospectively. RESULTS: The level of serum creatinine of 3 cadaver donors were 4.1 mg/dL (donor-A), 5.4 mg/dL (donor- B), 5.1 mg/dL (donor-C) before donation for renal allograft, and 1.1 mg/dL (donor-A), 1.2 mg/dL (donor-B), 1.1 mg/dL (donor-C) on admission. Total 5 patients received renal allografts from 3 cdaveric donors. 4 cases of these received hemodialysis during 2 weeks after operation, and another 1 case received peritoneal dialysis for 6 days after operation, and then hemodialysis for 9 days. 1 case (A-2) of recipients transplanted from donor A did not recovered and the graft kidney was abandoned. The rest 4 cases recovered uneventfully and serum creatinine levels were normailzed. Until recent follow up, serum creatinine levels were normal. CONCLUSION: In the situation of absolute shortage of donated graft organ, the use of marginal donor is inevitable. Among marginal donor criteria, the acceptance level for high serum creatinine is not confirmed yet. However, brain death patients who previously was healthy but recently deteriorated kidney due to hypotension episodes could be a candidate for transplantation donor. But a large study with long-term follow-up is required in order to expand their clinical indication.
Allografts ; Brain Death ; Cadaver* ; Creatinine ; Follow-Up Studies ; Humans ; Hypotension ; Kidney ; Kidney Transplantation* ; Peritoneal Dialysis ; Renal Dialysis ; Retrospective Studies ; Tissue Donors ; Transplantation ; Transplants

BACKGROUND: Treatment of toenail onychomycosis requires long term oral medication of antifungal agent. So many factors such as preferred treatment option can affect the compliance and cure rate. OBJECTIVES: The objective of the present study was to identify most preferred treatment options for toenail onychomycosis patients. METHODS: This study was undertaken on 190 patients treated toenail onychomycosis, who visited Hanyang University Guri hospital, Konkuk University hospital and Asan Medical center during the period between March 2008 to April 2008. RESULTS: 1. Mean age of patients was 53.5+/-15.5 years old, 108 patients (56.8%) were female and 82 patients (43.2%) were male. 2. Mean duration of disease was 7 years 11 months (7.9+/-8.8 years). 3. The motives of treatment for toenail onychomycosis were 'ugly appearance' (39.8%) and 'pruritus' (33.9%). 4. Seventy six percent of patients had history of treatment for toenail onychomycosis. Most of them (43%) visited dermatologist's office and 14% of them used folk remedy. 5. Continuous therapy was the most common method (47%) in previous treatment. And it was the most common treatment option irrespective of age, disease duration and gender. 6. The most preferred treatment option was also continuous therapy (57%). And 69% of patients who received continuous therapy preferred it, but it was only 48% in pulse therapy group and 38% in weekly pulse therapy group. 7. Sixty six percent of the toenail onychomycosis patients had associated disease. CONCLUSIONS: Continuous therapy was the most convenient method for toenail onychomycosis patients who visited general hospital.
Compliance ; Female ; Hospitals, General ; Humans ; Nails ; Onychomycosis

OBJECTIVE: To evaluate the usefulness of alendronate for prevention and treatment of postmenopausal osteoporosis this study was taken. METHODS: This prospective randomized clinical trial examined the effects of oral alendronate and HRT(conjugated estrogen plus medroxyprogesterone acetate), in combination and seperately, on BMD, biochemical markers of bone turnover in 79 women with low bone mass. Treatment included alendronate(10mg daily) plus HRT(group I, n=38), or HRT(group II, n=41) for 6 months. Bone density measurements were performed at months 0 and 6 at the lumbar spine. Biochemical markers of bone turnover were also measured every three months. RESULTS: Serum Osteocalcin decreased by 19.2% in group I and by 10.0% in group II at 3 months(p<0.05), and by 30.9% in group I and by 19.8% in group II at 6 months(p<0.05). Urinary deoxypyridinoline showed decrease of 19.75%(I) vs. 10.4%(II) at 3 months, 30.1%(I) vs. 20.7%(II) at 6 months, the difference was significant. Percent change of BMD measurements from baseline at 6 months in group I was 6.2% and in group II 0.6% on the lumbar spine(p<0.05). CONCLUSION: The treatment with alendronate is useful to postmenopausal women with osteoporosis by decreasing bone turnover markers, and by increasing the BMD.
Alendronate* ; Biomarkers ; Bone Density ; Estrogens ; Female ; Humans ; Medroxyprogesterone ; Osteocalcin ; Osteoporosis* ; Osteoporosis, Postmenopausal ; Prospective Studies ; Spine

No abstract available.
Animals ; Horns* ; Pregnancy*

BACKGROUND: Acute pain can severely interfere with the activities of daily living (ADL) of patients with herpes zoster, but until now, little has been published in the Korean medical literature about the impact of herpes zoster on the ADL. OBJECTIVE: The objective of this study was to identify the nature and severity of the acute pain of herpes zoster patients and its relationship to the patients' ADL. METHODS: 86 patients with herpes zoster and who visited our hospital from August 2009 to June 2010 were evaluated in regard to age, gender, the dermatomal distribution, the associated diseases, the severity and nature of the pain and the ADL. The nature of the pain was measured by the Short Form McGill Pain Questionnaire. To access interference of pain with the ADL, we used the Zoster Brief Pain Inventory (ZBPI) and the Zoster Impact Questionnaire (ZIQ). RESULTS: The mean onset of pain was 5.6+/-3.2 days before the visit, and the mean onset of skin lesion was 4.2+/-2.2 days before the visit. The most common nature of the pain of herpes zoster was shooting pain (55.8%), followed by stabbing pain (54.7%). But there was no significant difference of gender, age, the dermatomal distribution, the clinical severity and the associated disease according to the severity and nature of the pain. For every 1.0 point increase in the pain score, there was a 0.257 and 0.105 point increase in the ZBPI and ZIQ scores, respectively, on the multivariate linear regression model. CONCLUSION: This study will help to choose appropriate treatments to reduce the pain of patients who suffer with herpes zoster.
Activities of Daily Living ; Acute Pain ; Herpes Zoster ; Humans ; Linear Models ; Pain Measurement ; Quality of Life ; Skin

BACKGROUND: Acute pain can severely interfere with the activities of daily living (ADL) of patients with herpes zoster, but until now, little has been published in the Korean medical literature about the impact of herpes zoster on the ADL. OBJECTIVE: The objective of this study was to identify the nature and severity of the acute pain of herpes zoster patients and its relationship to the patients' ADL. METHODS: 86 patients with herpes zoster and who visited our hospital from August 2009 to June 2010 were evaluated in regard to age, gender, the dermatomal distribution, the associated diseases, the severity and nature of the pain and the ADL. The nature of the pain was measured by the Short Form McGill Pain Questionnaire. To access interference of pain with the ADL, we used the Zoster Brief Pain Inventory (ZBPI) and the Zoster Impact Questionnaire (ZIQ). RESULTS: The mean onset of pain was 5.6+/-3.2 days before the visit, and the mean onset of skin lesion was 4.2+/-2.2 days before the visit. The most common nature of the pain of herpes zoster was shooting pain (55.8%), followed by stabbing pain (54.7%). But there was no significant difference of gender, age, the dermatomal distribution, the clinical severity and the associated disease according to the severity and nature of the pain. For every 1.0 point increase in the pain score, there was a 0.257 and 0.105 point increase in the ZBPI and ZIQ scores, respectively, on the multivariate linear regression model. CONCLUSION: This study will help to choose appropriate treatments to reduce the pain of patients who suffer with herpes zoster.
Activities of Daily Living ; Acute Pain ; Herpes Zoster ; Humans ; Linear Models ; Pain Measurement ; Quality of Life ; Skin